{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T12:29:31Z","timestamp":1790166571385,"version":"4.1.0"},"reference-count":42,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2010,5,17]],"date-time":"2010-05-17T00:00:00Z","timestamp":1274054400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mycoses"],"published-print":{"date-parts":[[2011,9]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>The results of the use of ozonised sunflower oil (OLEOZON<jats:sup>\u00ae<\/jats:sup>) in the treatment of onychomycosis, based on its known antimycotic action and good skin tolerance, by means of a controlled randomised phase III assay are presented. A total of 400 outpatients were randomly divided into two groups: experimental, treated with topical OLEOZON<jats:sup>\u00ae<\/jats:sup>, two times per day and control, treated also two times per day, with ketoconazole cream 2%, for 3\u2003months. A patient was considered cured when the sick nails regained the normal colour, growth and thickness, with a negative mycological study. In the experimental group, a regression of signs was achieved from the first month of treatment, while in the control group, it was obtained after the third month of treatment. All patients treated with OLEOZON<jats:sup>\u00ae<\/jats:sup> had improvement in their condition (9.5%) or were cured (90.5%). However, in the control group, only 13.5% of patients were cured, 27.5% improved and 59% remained the same, with significant differences between both the groups. After 1\u2003year of follow\u2010up, experimental and control groups presented 2.8% and 44.4% of relapses, respectively. Topical OLEOZON<jats:sup>\u00ae<\/jats:sup> demonstrated effectiveness in the treatment of onychomycosis, superior to that of ketoconazole. No side effects were observed.<\/jats:p>","DOI":"10.1111\/j.1439-0507.2010.01898.x","type":"journal-article","created":{"date-parts":[[2010,5,18]],"date-time":"2010-05-18T04:36:16Z","timestamp":1274157376000},"source":"Crossref","is-referenced-by-count":37,"title":["Therapeutic efficacy of topical OLEOZON<sup>\u00ae<\/sup> in patients suffering from onychomycosis"],"prefix":"10.1111","volume":"54","author":[{"given":"Silvia","family":"Men\u00e9ndez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leopoldina","family":"Falc\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yordana","family":"Maqueira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,9,13]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1086\/313748"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.149.s65.4.x"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0733-8635(05)70323-5"},{"key":"e_1_2_7_5_2","first-page":"233","volume-title":"Dermatolog\u00eda","author":"Sim\u00f3n RD","year":"2002"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(08)81277-7"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.149.s65.5.x"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.138.6.811"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(98)70481-5"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1159\/000246174"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1159\/000017990"},{"issue":"2","key":"e_1_2_7_12_2","first-page":"157","article-title":"Relapse rate of onychomycosis after systemic treatment with terbinafine or itraconazole: a 2\u2010year follow\u2010up","volume":"7","author":"Tosti A","year":"1996","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(98)70487-6"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0733-8635(05)70420-4"},{"key":"e_1_2_7_15_2","first-page":"54","article-title":"How to treat special populations suffering from onychomycosis","volume":"7","author":"Gupta AK","year":"1999","journal-title":"Skin Aging"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200022010-00004"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.2165\/00128071-200405040-00003"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1999.00007.x"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.138.3.353"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.317.7165.1084"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.140.6.691"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2001.04378.x"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1080\/09546630310017834"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-4362.2001.01039.x"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1080\/01919510108961986"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1080\/01919510008547221"},{"key":"e_1_2_7_27_2","first-page":"209","article-title":"Actividad in vitro del OLEOZON frente a agentes etiol\u00f3gicos de infecciones de la piel","volume":"29","author":"Lezcano I","year":"1998","journal-title":"Rev CENIC Ciencias Biol\u00f3gicas (Cuba)"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2672.2001.01235.x"},{"key":"e_1_2_7_29_2","unstructured":"VignaI Men\u00e9ndezS.Eficacia de la ozonoterapia en gatos con diferentes enfermedades oftalmol\u00f3gicas. RECVET [WWW document] Nov 2007; II(11). URLhttp:\/\/www.veterinaria.org\/revistas\/recvet\/n111107.html[accessed on 1 November 2007]"},{"key":"e_1_2_7_30_2","first-page":"192","article-title":"Aceite Ozonizado en Dermatolog\u00eda. Experiencia de 9 a\u00f1os","volume":"29","author":"Falc\u00f3n L","year":"1998","journal-title":"Rev CENIC Ciencias Biol\u00f3gicas (Cuba)"},{"key":"e_1_2_7_31_2","first-page":"23","article-title":"Eficacia y seguridad del OLEOZON\u00ae t\u00f3pico en el tratamiento de pacientes con imp\u00e9tigo","volume":"9","author":"Men\u00e9ndez S","year":"2007","journal-title":"Rev Panam de Infectol"},{"key":"e_1_2_7_32_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1439-0507.2002.00780.x"},{"key":"e_1_2_7_33_2","first-page":"55","article-title":"Safety of topical OLEOZON\u00ae in the treatment of tinea pedis: phase IV clinical trial","volume":"7","author":"Men\u00e9ndez S","year":"2008","journal-title":"Int J Ozone Therapy"},{"key":"e_1_2_7_34_2","first-page":"T4","article-title":"Ensayo de toxicidad d\u00e9rmica de 120 d\u00edas del aceite ozonizado, OLEOZON, en ratas Cenp. SPRD","volume":"4","author":"Acevedo F","year":"1997","journal-title":"Avances en Biotecnolog\u00eda Moderna (Cuba)"},{"key":"e_1_2_7_35_2","first-page":"57","article-title":"Clasificaci\u00f3n toxicol\u00f3gica del OLEOZON\u00ae","volume":"32","author":"Arteaga ME","year":"2001","journal-title":"Rev CENIC Cienc Biol (Cuba)"},{"key":"e_1_2_7_36_2","first-page":"104","article-title":"Irritabilidad d\u00e9rmica del Oleozon\u00ae","volume":"26","author":"Llerena C","year":"1995","journal-title":"Rev CENIC Cienc Biol (Cuba)"},{"key":"e_1_2_7_37_2","first-page":"31","article-title":"Efecto histol\u00f3gico y bioqu\u00edmico del OLEOZON\u00ae en el modelo de la cola de rat\u00f3n","volume":"28","author":"Mart\u00ednez G","year":"1997","journal-title":"Rev CENIC Cienc Biol (Cuba)"},{"key":"e_1_2_7_38_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00011-007-7034-1"},{"key":"e_1_2_7_39_2","first-page":"100","article-title":"Evaluaci\u00f3n genot\u00f3xica del Oleozon\u00ae","volume":"28","author":"Remigia A","year":"1998","journal-title":"Rev CENIC Cienc Biol (Cuba)"},{"key":"e_1_2_7_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(96)90675-1"},{"key":"e_1_2_7_41_2","doi-asserted-by":"publisher","DOI":"10.1159\/000246182"},{"key":"e_1_2_7_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(99)70055-1"},{"key":"e_1_2_7_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0733-8635(05)70460-5"}],"container-title":["Mycoses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1439-0507.2010.01898.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1439-0507.2010.01898.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T04:05:41Z","timestamp":1697256341000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1439-0507.2010.01898.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["10.1111\/j.1439-0507.2010.01898.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1439-0507.2010.01898.x","archive":["Portico"],"relation":{},"ISSN":["0933-7407","1439-0507"],"issn-type":[{"value":"0933-7407","type":"print"},{"value":"1439-0507","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9]]}}}